Tags

Type your tag names separated by a space and hit enter

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
Lancet Infect Dis. 2020 10; 20(10):1119-1120.LI

Links

Publisher Full Text
ncbi.nlm.nih.gov
linkinghub.elsevier.com
PMC Free PDF
Aggregator Full Text

Authors+Show Affiliations

Tilangi P
Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Desai D
Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Khan A
Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Soneja M
Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India. Electronic address: manishsoneja@gmail.com.

MeSH

BetacoronavirusCOVID-19Coronavirus InfectionsHumansHydroxychloroquineIndiaPandemicsPneumonia, ViralSARS-CoV-2

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32450054

Citation

Tilangi, Praveen, et al. "Hydroxychloroquine Prophylaxis for High-risk COVID-19 Contacts in India: a Prudent Approach." The Lancet. Infectious Diseases, vol. 20, no. 10, 2020, pp. 1119-1120.
Tilangi P, Desai D, Khan A, et al. Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach. Lancet Infect Dis. 2020;20(10):1119-1120.
Tilangi, P., Desai, D., Khan, A., & Soneja, M. (2020). Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach. The Lancet. Infectious Diseases, 20(10), 1119-1120. https://doi.org/10.1016/S1473-3099(20)30430-8
Tilangi P, et al. Hydroxychloroquine Prophylaxis for High-risk COVID-19 Contacts in India: a Prudent Approach. Lancet Infect Dis. 2020;20(10):1119-1120. PubMed PMID: 32450054.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach. AU - Tilangi,Praveen, AU - Desai,Devashish, AU - Khan,Adil, AU - Soneja,Manish, Y1 - 2020/05/22/ PY - 2020/04/19/received PY - 2020/05/07/accepted PY - 2020/5/26/pubmed PY - 2020/10/2/medline PY - 2020/5/26/entrez SP - 1119 EP - 1120 JF - The Lancet. Infectious diseases JO - Lancet Infect Dis VL - 20 IS - 10 SN - 1474-4457 UR - https://www.unboundmedicine.com/medline/citation/32450054/Hydroxychloroquine_prophylaxis_for_high_risk_COVID_19_contacts_in_India:_a_prudent_approach_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(20)30430-8 DB - PRIME DP - Unbound Medicine ER -